Core Allegations - CoreWeave, Inc. is accused of misleading investors about its capacity to meet customer demand for its services [2] - The company allegedly overstated its ability to accommodate customer demand and understated the risks associated with reliance on a single third-party data center supplier [2] - These misrepresentations are believed to have a material negative impact on the company's revenue [2] Stock Performance - CoreWeave's stock price experienced a significant decline, dropping from a high of $183.58 on June 20, 2025, to a closing price of $69.50 per share on December 16, 2025 [3] Class Action Details - A class action has been filed on behalf of investors who purchased CoreWeave securities between March 28, 2025, and December 15, 2025 [1] - Shareholders wishing to serve as lead plaintiff must submit their papers to the court by March 13, 2026 [4] - Participation in the case is not required to be eligible for recovery, allowing shareholders to remain absent class members if they choose [4]

Group 1 - The article does not provide any relevant content regarding the company or industry [1]

Core Viewpoint - UroGen Pharma Ltd. is focused on developing innovative solutions for urological and uro-oncological diseases, with key products showing growth and strategic initiatives aimed at enhancing market presence and financial stability [1][5]. Financial Performance - UroGen Pharma reported a quarterly loss of $0.54 per share for Q4 2025, which is better than the Zacks Consensus Estimate of a $0.66 loss and an improvement from the $0.80 loss in the same quarter last year, indicating an 18.18% positive earnings surprise [3][6]. - The company achieved $37.84 million in revenue for Q4 2025, surpassing the Zacks Consensus Estimate by 6.42% and showing significant growth from $24.57 million in the same quarter the previous year [4][6]. Stock Performance - Oppenheimer reiterated its "Outperform" rating for UroGen Pharma, maintaining a stock price of $19.93 at the time of the report, despite a recent decrease of 8.06% [2]. - The stock has fluctuated between $18.18 and $21.69, with a market capitalization of approximately $933.8 million [2]. Strategic Initiatives - UroGen launched ZUSDURI™, achieving net sales of $15.8 million in 2025, and the introduction of a permanent J Code effective January 1, 2026, is expected to improve reimbursement processes and patient access [5][6]. - The company has refinanced its existing term loan with Pharmakon Advisors, securing additional non-dilutive capital under more favorable terms [5].

Core Viewpoint - The ongoing U.S.-Israel conflict with Iran poses significant risks to oil and gas production for companies like Exxon Mobil, TotalEnergies, and Shell, while simultaneously driving up energy prices, which may benefit their profits [1]. Group 1: Company Exposure - Exxon Mobil has 20% of its oil and gas output in the Middle East, while TotalEnergies has 29% and Shell also has 20% [1]. - Nearly 60% of Exxon's liquefied natural gas (LNG) business is concentrated in the Middle East, making it particularly vulnerable to disruptions [1]. - TotalEnergies has oil and gas production operations in the UAE, and Shell has a significant presence in Oman [1]. Group 2: Impact of Conflict - The conflict has led to the shutdown of some oil and gas fields and has effectively halted shipping through the Strait of Hormuz, a critical waterway for oil transport [1]. - Brent crude futures increased by approximately 7% to $77.74 per barrel, while the European natural gas benchmark surged by about 40% [1]. - QatarEnergy, a partner of Exxon, TotalEnergies, and Shell, halted LNG production following Iranian drone attacks, impacting about 20% of global LNG supply [1]. Group 3: Future Prospects - Exxon is expected to benefit from the startup of its Golden Pass LNG project in Texas, which is anticipated to begin production this month [1].

Group 1 - Major indexes showed little movement on Monday despite geopolitical tensions, particularly warnings from Donald Trump regarding a prolonged conflict in Iran [1]

Economic Impact of Iran Conflict - The economic effect of the Iran conflict could worsen if the war continues for an extended period [1] - The war primarily threatens the U.S. economy by jeopardizing oil passage through the Strait of Hormuz, a critical point in global oil supply chains [1] - Economists predict that gas prices may increase by 10 to 30 cents per gallon, while the overall impact on inflation and consumer spending is expected to be modest [1] Market Reactions - Following the U.S. and Israel's military actions against Iran, crude oil futures surged approximately 7%, and natural gas futures rose by 3.25% [1] - The rise in oil prices is noted as the 38th-highest spike since 1990, which is less severe than previous shocks such as the COVID-19 pandemic and the 2019 Saudi oil facility attack [1] Future Economic Outlook - The U.S. economy is anticipated to withstand the shock from the conflict, similar to its resilience during past disruptions like tariffs and Federal Reserve independence threats [1] - The duration of the conflict will significantly influence whether it causes a minor blip or a more severe economic crisis [1] - A prolonged conflict could lead to significantly higher oil prices, potentially stoking inflation and undermining consumer confidence [1] Energy Market Implications - The energy market is identified as the primary channel through which the conflict may impact global markets [1] - Sustained disruptions to oil or natural gas flows could influence inflation expectations and increase volatility across asset classes [1] - Economists suggest that a substantial increase in oil prices would be necessary to severely harm the U.S. economy, with simulations indicating that 10% and 30% sustained increases would not lead to a recession [1] Risks of Escalation - There is a growing risk that multiple shocks could compound the economic impact, particularly if disruptions in the Strait of Hormuz coincide with other regional conflicts [1] - The future stability of the Middle East and energy prices will depend on the conflict's duration and the nature of any regime change [1]

Core Insights - JPMorgan Chase CEO Jamie Dimon highlighted the potential for retaliatory cyberattacks against banks due to U.S. military actions in Iran [1] - Dimon stated that unless the conflict leads to a prolonged disruption of oil trade, it is unlikely to cause a significant inflationary impact in the U.S. [1] - The warning from Iran regarding the Strait of Hormuz, a critical oil transit route, has raised concerns about potential disruptions to global oil supply [1] Group 1: Economic Impact - Dimon indicated that the recent U.S. strikes on Iran could lead to short-term spikes in oil prices, but these are not expected to have a lasting effect on consumer prices if the situation is resolved quickly [1] - He noted that while there may be a temporary increase in gas prices, a prolonged conflict would be necessary for a major inflationary impact [1] - The conflict has already caused West Texas Intermediate futures to rise to an 8-month high, reflecting market concerns about oil supply disruptions [1] Group 2: Cybersecurity Concerns - Dimon emphasized that banks, including JPMorgan Chase, could be prime targets for cyberattacks as a form of retaliation [1] - He described the risk of cyberattacks as one of the highest risks faced by banks and mentioned the significant investments made in cybersecurity to mitigate these threats [1] - The potential for terrorist attacks, either domestically or globally, was also highlighted as a consequence of the ongoing conflict [1]

Core Insights - A recent court ruling has placed borrowers in the Saving on a Valuable Education (SAVE) repayment plan in a state of uncertainty, as the legality of the plan has been challenged through various lawsuits [1][2] - The Department of Education may have the opportunity to lift the administrative forbearance and resume payments under the SAVE plan following the dismissal of the main lawsuit, but it is uncertain if they will take this action [2][5] Group 1: Current Status of the SAVE Plan - There are currently 7.43 million borrowers enrolled in the SAVE plan, which was designed to provide lower monthly payments and a faster path to forgiveness [2] - Borrowers remain in administrative forbearance, meaning they are not required to make payments, but any payments made during this period do not contribute towards time-based forgiveness [4][8] Group 2: Future of the SAVE Plan - The Department of Education under the Trump administration has shown resistance to the Biden-era repayment plan, making it unlikely that forbearance will be lifted soon [4] - The SAVE plan is set to be phased out by July 2028, after which only the newly created Repayment Assistance Plan (RAP) and the existing Income-Based Repayment (IBR) plan will be available [8][9] Group 3: Borrower Guidance - Borrowers on the SAVE plan can transition to the RAP plan starting in July, but they can request entry into the IBR plan now, although they may face significant delays due to a backlog of over 600,000 pending applications [10] - It is advised that borrowers check their federal loan servicer information and consider enrolling in the IBR plan, which is viewed as a more stable option compared to the SAVE plan [11]

Core Insights - Viavi Solutions Inc. is a key player in the network testing and security industry, known for its innovative solutions that enhance network reliability and security [1] Executive Transactions - On March 2, 2026, McNab Paul, the Executive Vice President, sold 3,551 shares at $32.89 each, retaining 18,198 shares [2] - On February 9, 2026, Oleg Khaykin, the President and CEO, sold 73,250 shares at approximately $26.25 each, totaling around $1.9 million, reducing his direct holdings by 4.19% to 1,635,621 shares [3] Financial Metrics - Viavi has a negative price-to-earnings (P/E) ratio of -186.70, indicating negative earnings over the past year, while its price-to-sales ratio is 6.48, suggesting investor confidence in revenue potential [4] - The enterprise value to sales ratio is 6.94, and the enterprise value to operating cash flow ratio is 82.10, indicating a high valuation relative to revenue and cash flow [5] - The debt-to-equity ratio stands at 1.59, showing significant use of debt, while a current ratio of 2.61 indicates strong short-term financial health [5][6]

We're watching Birkshire Hathaway. It's lower today. Did report its fourth quarter results.The first results out without Warren Buffett at the helm. Um he stepped aside. He obviously retired at the peak.And now McCrae Sykes is with me, portfolio manager of Gabelli Funds. Mack taking a look at what we saw from Bergkshire and Greg Ael who's now on board and says he's going to be on board maybe for 20 years. >> Yeah, thanks for having me Nicole.Um, great day for Berkshire Hathway, you know, in terms of getting ...